Skip to main content

stock

RNXT · RenovoRx, Inc.

What RenovoRx, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live RNXT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on RNXT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
45,129,508 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
84.4%
Operating
-685.2%
Net
-621.7%

Returns

ROE
-136.8%
ROA
-107.1%

Health

Current ratio
5.7x
Debt/equity
—

Deep value

NCAV
$8.32M
NCAV per share
$0.18
Price/NCAV
Locked
NNWC
$7.54M
NNWC per share
$0.17
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$909,000$766,000-$3.35M-$2.91M
10-Q filed 2026-08-13
2026-03-31$563,000$479,000-$3.47M-$3.52M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$238,000$210,000-$3.52M-$2.94M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$266,000$213,000-$3.20M-$2.91M
10-Q filed 2025-11-13
2025-06-30$422,000$270,000-$2.68M-$2.90M
10-Q filed 2026-08-13
2025-03-31$197,000$103,000-$3.11M-$2.42M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$2.63M-$2.88M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$2.83M-$2.47M
10-Q filed 2025-11-13
Assets
$11.47M
Equity
$8.98M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$1.12M-$12.51M-$11.17M-$10.97M
2024-12-31$43,000-$10.97M-$8.81M-$9.14M
2023-12-31—-$11.40M-$10.23M—
2022-12-31—-$9.95M-$9.89M—
2021-12-31—-$5.67M-$6.32M—
2020-12-31—-$3.20M-$3.80M—

Company filings

since Thu Apr 16 · 2 offering filings in 12 months · since Fri Nov 14

events

  • Other event

    Other event
    Aug 208-K
  • Results

    Results
    Aug 138-K/A
  • 8-K

    Aug 128-K
  • Other event

    Other event
    Aug 48-K
  • Listing standard notice

    Listing standard notice
    Jul 28-K
  • Shareholder vote results

    Shareholder vote results
    Jun 308-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named RNXT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about RNXT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about RNXT.

nakagai

Signals on RNXT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the RNXT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

RenovoRx, Inc. (RNXT): SEC filings, financials and insider trades · Nakagai